Armephaco JSC

Armephaco JSC Capital Expenditures

The Capital Expenditures (CapEx) of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is -6.63 B VND. In the previous year, Capital Expenditures (CapEx) was -7.08 B VND — a change of -6.38% (higher).

Capital Expenditures

-6.63 BVND

YoY

-6.38%

Last updated:

Capital Expenditures (CapEx) of Armephaco JSC is 2024 -6.63 B VND. Capital Expenditures (CapEx) of Armephaco JSC was 2023 -7.08 B VND. It decreases by -6.38% higher compared to the previous year.

The Armephaco JSC Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2017
-4.00 B VND
Jan 1, 2018
-1.71 B VND
Jan 1, 2019
-1.12 B VND
Jan 1, 2020
-7.70 B VND
Jan 1, 2021
-4.78 B VND
Jan 1, 2022
-1.22 B VND
Jan 1, 2023
-7.08 B VND
Jan 1, 2024
-6.63 B VND
The Armephaco JSC Capital Expenditures history
YEARCapital ExpendituresYoY
-6.63 BVND-6.38%
-7.08 BVND+479.28%
-1.22 BVND-74.40%
-4.78 BVND-37.93%
-7.70 BVND+589.78%
-1.12 BVND-34.66%
-1.71 BVND-57.31%
-4.00 BVND+25.90%
-3.18 BVND-70.94%
-10.94 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Capital Expenditures (CapEx) of Armephaco JSC is -6.63 B VND in 2024.

Capital Expenditures (CapEx) of Armephaco JSC changed from -7.08 B VND to -6.63 B VND, representing a -6.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Armephaco JSC

All Key Metrics — Armephaco JSC